# Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms

> **NCT00391417** · PHASE3 · COMPLETED · sponsor: **BioSante Pharmaceuticals** · enrollment: 431 (—)

## Conditions studied

- Hot Flashes

## Interventions

- **DRUG:** estradiol gel

## Key facts

- **NCT ID:** NCT00391417
- **Lead sponsor:** BioSante Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2005-04
- **Target enrollment:** 431 (—)
- **Last updated:** 2006-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00391417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00391417, "Efficacy and Safety of a Topical Estradiol Gel for Treatment of Postmenopausal Symptoms". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT00391417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*